Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist.
AuthorsShalet, Stephen M
AffiliationDepartment of Endocrinology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK.
MetadataShow full item record
AbstractIn the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients.
CitationExtensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist. 2013, 169 (4):R81-7 Eur J Endocrinol
JournalEuropean Journal of Endocrinology
- Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
- Authors: Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P, KIMS Study Group.
- Issue date: 2005 Oct
- Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
- Authors: Hoybye C, Jönsson P, Monson JP, Koltowska-Häggström M, Hána V, Geffner M, Abs R
- Issue date: 2007 Nov
- Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.
- Authors: Johannsson G, Touraine P, Feldt-Rasmussen U, Pico A, Vila G, Mattsson AF, Carlsson M, Korbonits M, van Beek AP, Wajnrajch MP, Gomez R, Yuen KCJ
- Issue date: 2022 Jun 16
- Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.
- Authors: He X, Barkan AL
- Issue date: 2020 Jun
- Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency.
- Authors: Miljic D, Miljic P, Doknic M, Pekic S, Stojanovic M, Cvijovic G, Micic D, Popovic V
- Issue date: 2013 Dec